Abstract
Compounds that can bind to and stabilize quadruplex DNA structures in telomeres, or induce formation of such structures from ssDNA, represent an attractive general approach to the treatment of cancer. Until recently most effort in this area has been directed towards the synthesis of organic compounds for this purpose. More recently there has been growing recognition that metal complexes offer a number of potential advantages for the preparation of lead complexes that bind with high affinity and selectivity for quadruplex DNA. This review seeks to discuss the work that has been reported in this area to date. While most early studies focused on metal complexes of porphyrin ligands, during the past 4 years there has been a dramatic increase in the number of papers in the literature examining the potential of mononuclear complexes of a variety of other ligands, particularly Schiff base ligands and those based on phenanthroline, as quadruplex DNA binders and telomerase inhibitors. In addition, there has been growing interest in exploiting supramolecular chemistry to prepare novel multinuclear complexes that bind to this new drug target.
Keywords: Quadruplex DNA, telomerase, metal complex, porphyrin, absorption spectroscopy, qDNA, cancer, G-tetrads, PLATINUM COMPLEXES, FRET analysis, Fibre X-ray diffraction, stacking interactions, Mass spectrometric analysis, Fluorescence Intercalator Displacement (FID) assay, PAGE analysis
Current Topics in Medicinal Chemistry
Title: Quadruplex DNA: A Promising Drug Target for the Medicinal Inorganic Chemist
Volume: 11 Issue: 5
Author(s): Stephen F. Ralph
Affiliation:
Keywords: Quadruplex DNA, telomerase, metal complex, porphyrin, absorption spectroscopy, qDNA, cancer, G-tetrads, PLATINUM COMPLEXES, FRET analysis, Fibre X-ray diffraction, stacking interactions, Mass spectrometric analysis, Fluorescence Intercalator Displacement (FID) assay, PAGE analysis
Abstract: Compounds that can bind to and stabilize quadruplex DNA structures in telomeres, or induce formation of such structures from ssDNA, represent an attractive general approach to the treatment of cancer. Until recently most effort in this area has been directed towards the synthesis of organic compounds for this purpose. More recently there has been growing recognition that metal complexes offer a number of potential advantages for the preparation of lead complexes that bind with high affinity and selectivity for quadruplex DNA. This review seeks to discuss the work that has been reported in this area to date. While most early studies focused on metal complexes of porphyrin ligands, during the past 4 years there has been a dramatic increase in the number of papers in the literature examining the potential of mononuclear complexes of a variety of other ligands, particularly Schiff base ligands and those based on phenanthroline, as quadruplex DNA binders and telomerase inhibitors. In addition, there has been growing interest in exploiting supramolecular chemistry to prepare novel multinuclear complexes that bind to this new drug target.
Export Options
About this article
Cite this article as:
F. Ralph Stephen, Quadruplex DNA: A Promising Drug Target for the Medicinal Inorganic Chemist, Current Topics in Medicinal Chemistry 2011; 11 (5) . https://dx.doi.org/10.2174/156802611794785208
DOI https://dx.doi.org/10.2174/156802611794785208 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Sam Domain of EphA2 Receptor and its Relevance to Cancer: A Novel Challenge for Drug Discovery?
Current Medicinal Chemistry Cellular Actions of Gabapentin and Related Compounds on Cultured Sensory Neurones
Current Neuropharmacology Anti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer Therapy
Current Cancer Drug Targets Discovery of Cationic Polymers for Non-Viral Gene Delivery Using Combinatorial Approaches
Combinatorial Chemistry & High Throughput Screening Lipid Nanocarriers for Neurotherapeutics: Introduction, Challenges, Blood-brain Barrier, and Promises of Delivery Approaches
CNS & Neurological Disorders - Drug Targets Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein
Current Cancer Therapy Reviews Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
Current Pharmaceutical Design Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies Pluripotent Stem Cell-Derived Somatic Stem Cells as Tool to Study the Role of MicroRNAs in Early Human Neural Development
Current Molecular Medicine Calcium Level Controlling Activities of Novel Derivatives of Amlodipine,Riodipine and Cerebrocrast
Letters in Drug Design & Discovery Epigenetic Therapies of Cancer
Current Cancer Therapy Reviews Common Pathways in Health Benefit Properties of RSV in Cardiovascular Diseases, Cancers and Degenerative Pathologies
Current Pharmaceutical Biotechnology Phycobilins and Phycobiliproteins Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Recent Advances in Minimal Access Surgery for Infants and Children
Current Pediatric Reviews Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
Current Medicinal Chemistry Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases
Current Pharmaceutical Design A Review of Titanium Di Oxide Nanoparticles - Synthesis, Applications and Toxicity Concerns
Nanoscience & Nanotechnology-Asia Contribution of Inflammatory Processes to Nerve Cell Toxicity by Bilirubin and Efficacy of Potential Therapeutic Agents
Current Pharmaceutical Design Editorial (A Significant Step Towards New Altitude)
Current Molecular Medicine Extracellular Targeting of Synthetic Therapeutic Nucleic Acid Formulations
Current Gene Therapy